Peter Savage - Sonic Healthcare Chief Officer
| SKHHY Stock | USD 18.51 0.38 2.10% |
Insider
Peter Savage is Chief Officer of Sonic Healthcare Ltd
| Phone | 61 2 9855 5444 |
| Web | https://www.sonichealthcare.com |
Sonic Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.1111 % which means that it generated a profit of $0.1111 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2175 %, meaning that it generated $0.2175 on every $100 dollars invested by stockholders. Sonic Healthcare's management efficiency ratios could be used to measure how well Sonic Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mickey MD | Caredx Inc | N/A | |
| Ayman MD | Precipio | 39 | |
| Petra Ploesser | Mainz Biomed BV | N/A | |
| Moritz Eidens | Mainz Biomed BV | 40 | |
| Corinna Gorges | Mainz Biomed BV | N/A | |
| Constance Ward | Lonza Group | N/A | |
| Janice Meraglia | Applied DNA Sciences | N/A | |
| Keith Meadors | Precipio | N/A | |
| Bobbi Coffin | Biodesix | N/A | |
| Jeffrey Bojar | Biodesix | N/A | |
| Matt Stauffer | Biodesix | N/A | |
| Billy White | ProPhase Labs | 63 | |
| Erin Smith | Twist Bioscience Corp | N/A | |
| Andreas Bohrer | Lonza Group | N/A | |
| Philippe Deecke | Lonza Group | 51 | |
| Dr III | Biodesix | 53 | |
| Dirk Oehlers | Lonza Group | N/A | |
| Andrew Macan | Neuronetics | 51 | |
| Heinrich Rder | Biodesix | N/A | |
| Camilla Zuckero | Castle Biosciences | N/A | |
| LLM LLM | Natera Inc | 55 | |
Management Performance
| Return On Equity | 0.22 | |||
| Return On Asset | 0.11 |
Sonic Healthcare Leadership Team
Elected by the shareholders, the Sonic Healthcare's board of directors comprises two types of representatives: Sonic Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sonic. The board's role is to monitor Sonic Healthcare's management team and ensure that shareholders' interests are well served. Sonic Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sonic Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephen Fairy, Global Officer | ||
| Julian Adler, Chief Imaging | ||
| Mrs Schottdorf, Chief Group | ||
| FAICD FRCPA, MD CEO | ||
| BEc CA, Deputy Sec | ||
| BCom FACID, CFO Director | ||
| David Byrne, Chief Laboratory | ||
| Prashan Kulasekera, Assistant Sec | ||
| Peter Savage, Chief Officer |
Sonic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sonic Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.22 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 11.17 B | |||
| Shares Outstanding | 480.98 M | |||
| Shares Owned By Institutions | 0.23 % | |||
| Price To Earning | 14.03 X | |||
| Price To Book | 1.99 X | |||
| Price To Sales | 1.05 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sonic Pink Sheet Analysis
When running Sonic Healthcare's price analysis, check to measure Sonic Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonic Healthcare is operating at the current time. Most of Sonic Healthcare's value examination focuses on studying past and present price action to predict the probability of Sonic Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonic Healthcare's price. Additionally, you may evaluate how the addition of Sonic Healthcare to your portfolios can decrease your overall portfolio volatility.